Lancero, Hope

Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis

Ho, K. J., Spite, M., Owens, C. D., Lancero, H., Kroemer, A. H. K., Pande, R., Creager, M. A., Serhan, C. N., & Conte, M. S. (2010) · The American Journal of Pathology

Fatty Acid Research and HealthAtherosclerosis and Cardiovascular Diseases

Cited by 204

Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis

Kojima, Y., Downing, K., Kundu, R., Miller, C., Dewey, F., Lancero, H., Raaz, U., Perisic, L., Hedin, U., Schadt, E., et al. (2014) · Journal of Clinical Investigation

Atherosclerosis and Cardiovascular DiseasesPhagocytosis and Immune Regulation

Cited by 148